Health Canada is restricting the importation of drugs from Hospira S.P.A. in Liscate, Italy, a pharmaceutical manufacturing facility, due to data integrity concerns. This measure is to help mitigate any potential risk in light of recent findings from a trusted regulatory partner that raised concerns about the reliability of the laboratory data generated at this site.
Health Canada has compiled a list of marketed products affected by the importation restrictions. The list will be updated as new information becomes available.
For further information contact Health Canada at 613-957-2983/1-866-225-0709.